Product timeline

M6229 is currently in the pre-clinical phase.

Company details

Matisse Pharmaceuticals B.V.

Burgemeester Lemmensstraat 352

P.O. Box 1124, 6160 BC Geleen

The Netherlands

T +31 (0)88 255 40 10

info@matisse-pharma.com

 

Chamber of Commerce No 61302007

Follow us

  • Facebook - White Circle
  • Tumblr - White Circle
  • Google+ - White Circle
  • YouTube - White Circle

Newsletter

© 2017 Matisse Pharmaceuticals BV